Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

2001 • 156,143 citations

Mechanisms of angiogenesis

1997 • 5,696 citations

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 • 2,565 citations

Thalidomide is an inhibitor of angiogenesis.

1994 • 2,460 citations

Clinical Applications of Research on Angiogenesis

1995 • 2,300 citations

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

1992 • 1,799 citations

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1999 • 1,447 citations

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis

1977 • 1,286 citations

Biology and biochemistry of proteinases in tumor invasion

1993 • 1,264 citations

Proteasome inhibitors: from research tools to drug candidates

2001 • 1,159 citations

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

2003 • 880 citations

Bone marrow angiogenesis and progression in multiple myeloma

1994 • 656 citations

The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development

1999 • 651 citations

Quantification of cells cultured on 96-well plates

1989 • 644 citations

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

2001 • 562 citations

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

2001 • 481 citations

The proteasome inhibitor PS-341 in cancer therapy.

1999 • 475 citations

Molecular aspects of tumor cell invasion and metastasis

1993 • 463 citations

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

2002 • 462 citations

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

2001 • 420 citations

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

2004 • 335 citations

A novel mechanism of capillary growth in the rat pulmonary microcirculation

1990 • 277 citations

Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine

1999 • 271 citations

Angiogenesis Research: Guidelines for Translation to Clinical Application

2001 • 262 citations

New Model for the Study of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane: The Gelatin Sponge/ Chorioallantoic Membrane Assay

1997 • 225 citations

Angiogenesis Inhibitors Generated by Tumors

1995 • 214 citations

Novel therapies targeting the myeloma cell and its bone marrow microenvironment

2001 • 200 citations

MICROTUBULES AS DRUG RECEPTORS: PHARMACOLOGICAL PROPERTIES OF MICROTUBULE PROTEIN*

1975 • 196 citations

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

2004 • 189 citations

Endothelial cells in the bone marrow of patients with multiple myeloma

2003 • 177 citations

Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer

2002 • 172 citations

Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.

2002 • 169 citations

Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma

2003 • 169 citations

Endogenous Basic Fibroblast Growth Factor Is Implicated in the Vascularization of the Chick Embryo Chorioallantoic Membrane

1995 • 161 citations

Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells

2003 • 160 citations

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

2000 • 156 citations

Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity.

1995 • 147 citations

Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia.

2002 • 145 citations

A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.

2003 • 139 citations

The Proteasome Is Involved in Angiogenesis

1998 • 131 citations

Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis

1992 • 114 citations

A strategy to discover circulating angiogenesis inhibitors generated by human tumors.

1995 • 100 citations

The thin red line

2000 • 84 citations

Human Lung Microvessel Endothelial Cells: Isolation, Culture, and Characterization

1993 • 77 citations

Novel therapies for multiple myeloma

2002 • 76 citations

Antiangiogenesis by cyclosporine.

1998 • 48 citations

Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical–biological features

2001 • 33 citations

Novel therapies targeting the myeloma cell and its bone marrow microenvironment

2001 • 27 citations